1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PELI2 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA IDH2 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA TCERG1L CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA PPFIA2 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA MAU2 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA PGBD5 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA CXorf21 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ZNF362 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA CHN2 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA GMIP CTRPv2 pan-cancer AAC 0.21 3e-06
Download CSV